Farrer et al. suggested that although APOE ε4 represents a major risk factor for AD across all ages between 40 and 90 years in both sexes, the attenuated effect of APOE ε4 in some ethnicities was caused by small sample size, population heterogeneity, or other factors[10]. This evidence concerns the gene APOE and Alzheimer disease.